GT200600288A - Composiciones que contienen particulas magneticas de oxido de hierro, y uso de dichas composiciones en metodos de diagnostico por imagenes - Google Patents
Composiciones que contienen particulas magneticas de oxido de hierro, y uso de dichas composiciones en metodos de diagnostico por imagenesInfo
- Publication number
- GT200600288A GT200600288A GT200600288A GT200600288A GT200600288A GT 200600288 A GT200600288 A GT 200600288A GT 200600288 A GT200600288 A GT 200600288A GT 200600288 A GT200600288 A GT 200600288A GT 200600288 A GT200600288 A GT 200600288A
- Authority
- GT
- Guatemala
- Prior art keywords
- compositions
- iron oxide
- containing magnetic
- oxide particles
- magnetic iron
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
- A61B5/418—Evaluating particular organs or parts of the immune or lymphatic systems lymph vessels, ducts or nodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/0515—Magnetic particle imaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/411—Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
- A61B5/415—Evaluating particular organs or parts of the immune or lymphatic systems the glands, e.g. tonsils, adenoids or thymus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
- A61B5/416—Evaluating particular organs or parts of the immune or lymphatic systems the spleen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
- A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
- A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
- A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
- A61K49/1833—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with a small organic molecule
- A61K49/1836—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with a small organic molecule the small organic molecule being a carboxylic acid having less than 8 carbon atoms in the main chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
- A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
- A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
- A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
- A61K49/1851—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule
- A61K49/1863—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule the organic macromolecular compound being a polysaccharide or derivative thereof, e.g. chitosan, chitin, cellulose, pectin, starch
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
- A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
- A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
- A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
- A61K49/1866—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle the nanoparticle having a (super)(para)magnetic core coated or functionalised with a peptide, e.g. protein, polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
- A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
- A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
- A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
- A61K49/1875—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle coated or functionalised with an antibody
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Nanotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Medical Informatics (AREA)
- Biomedical Technology (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Radiology & Medical Imaging (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Crystallography & Structural Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Compounds Of Iron (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
LA PRESENTE INVENCIÓN SE REFIERE A COMPLEJOS QUE CONTIENEN PARTÍCULAS MAGNÉTICAS DE ÓXIDO DE HIERRO POLICRISTALINO EN UNA COBERTURA ACEPTABLE PARA USO FARMACÉUTICO, Y AL USO DE DICHAS COMPOSICIONES EN EL DIAGNÓSTICO POR IMÁGENES CON PARTÍCULAS MAGNÉTICAS (MPI). SE PREFIERE EN PARTICULAR EL USO DE DICHAS COMPOSICIONES EN LOS EXÁMENES DEL TRACTO GASTROINTESTINAL, DEL SISTEMA VASCULAR CARDÍACO Y COMPONENTES CRANEANOS, EN EL DIAGNÓSTICO DE ARTERIOSCLEROSIS, INFARTOS, Y TUMORES Y METÁSTASIS, POR EJEMPLO DEL SISTEMA LINFÁTICO. T2006
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05014058A EP1738773A1 (de) | 2005-06-29 | 2005-06-29 | Magnetische Eisenoxidpartikel enthaltende Zusammensetzung und deren Vervendung in bildgebenden Verfahren |
Publications (1)
Publication Number | Publication Date |
---|---|
GT200600288A true GT200600288A (es) | 2007-03-14 |
Family
ID=35432430
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GT200600288A GT200600288A (es) | 2005-06-29 | 2006-06-29 | Composiciones que contienen particulas magneticas de oxido de hierro, y uso de dichas composiciones en metodos de diagnostico por imagenes |
Country Status (14)
Country | Link |
---|---|
US (2) | US20070014730A1 (es) |
EP (2) | EP1738773A1 (es) |
JP (1) | JP5366543B2 (es) |
CN (1) | CN101365495B (es) |
AR (1) | AR054808A1 (es) |
BR (1) | BRPI0611756A2 (es) |
DO (1) | DOP2006000154A (es) |
GT (1) | GT200600288A (es) |
PA (1) | PA8684201A1 (es) |
PE (1) | PE20070345A1 (es) |
RU (1) | RU2420319C2 (es) |
TW (1) | TW200800275A (es) |
UY (1) | UY29643A1 (es) |
WO (1) | WO2007000351A1 (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1738774A1 (de) * | 2005-06-29 | 2007-01-03 | Schering AG | Magnetische Eisenoxidpartikel enthaltende Zusammensetzungen und deren Verwendung in bildgebenden Verfahren |
CN101600389A (zh) * | 2007-01-24 | 2009-12-09 | 皇家飞利浦电子股份有限公司 | 用于影响和/或探测作用区域中的磁性粒子的方法、磁性粒子以及磁性粒子的使用 |
EP2274024B1 (en) * | 2008-04-03 | 2013-05-15 | Koninklijke Philips Electronics N.V. | Biocompatible products for magnetic particle imaging |
EP2406650A1 (en) | 2009-03-09 | 2012-01-18 | Koninklijke Philips Electronics N.V. | Arrangement and method for measuring a magnetic material in a region of action |
KR101085824B1 (ko) * | 2009-03-11 | 2011-11-23 | 한국유나이티드제약 주식회사 | 생체적합성 고분자를 이용한 다기능성 조영제 및 이의 제조방법 |
WO2010128418A1 (en) | 2009-05-08 | 2010-11-11 | Koninklijke Philips Electronics N.V. | Arrangement and method for heating of a magnetic material |
JP5763631B2 (ja) * | 2009-07-01 | 2015-08-12 | コーニンクレッカ フィリップス エヌ ヴェ | Mpi誘導による薬物送達のための刺激応答性キャリア |
WO2011030271A1 (en) * | 2009-09-14 | 2011-03-17 | Koninklijke Philips Electronics N.V. | Apparatus and method for moving and activating an active agent |
WO2011163136A2 (en) | 2010-06-21 | 2011-12-29 | University of Washington Center for Commercialization | Tuned multifunctional magnetic nanoparticles for biomedicine |
US9555136B2 (en) | 2010-06-21 | 2017-01-31 | University Of Washington Through Its Center For Commercialization | Coated magnetic nanoparticles |
WO2012007871A1 (en) | 2010-07-13 | 2012-01-19 | Koninklijke Philips Electronics N.V. | System and method for generating a system function for use in the reconstruction of images |
RU2497546C1 (ru) * | 2012-04-23 | 2013-11-10 | Общество с ограниченной ответственностью "Ланда Фармасьютикалз" | Магнитно-резонансное и рентгеновское контрастное средство и способ его получения |
CN103316361B (zh) * | 2013-07-08 | 2015-04-01 | 武汉百仕康生物科技有限公司 | 一种稳定的纳米级超顺磁氧化铁溶液及其制备方法和应用 |
CN103704232B (zh) * | 2013-11-01 | 2016-01-06 | 北京科技大学 | 纳米农药羧甲基-β-环糊精-Fe3O4磁性纳米-敌草隆的制备方法 |
JP6220894B2 (ja) * | 2013-12-13 | 2017-10-25 | 有限会社マーキュリーアセットマネジメント | 関節軟骨の変性部位の可視化用組成物 |
US10898581B2 (en) * | 2014-01-16 | 2021-01-26 | The Brigham And Women's Hospital, Inc. | Targeted delivery of immunoregulatory drugs |
JP2019151552A (ja) * | 2016-07-12 | 2019-09-12 | 名糖産業株式会社 | 磁性粒子 |
KR20200017820A (ko) * | 2018-08-09 | 2020-02-19 | (주)아모레퍼시픽 | 미세먼지 제거용 다공성 복합분체 및 이의 제조방법 |
CN111298140B (zh) * | 2020-03-24 | 2022-04-19 | 中国科学院苏州纳米技术与纳米仿生研究所 | 还原响应的t1/t2切换型mri造影剂、其制备方法及应用 |
CN115125537B (zh) * | 2022-08-05 | 2023-04-11 | 四川轻化工大学 | 一种脱除聚晶金刚石复合片中钴的方法 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4102780A (en) * | 1976-03-09 | 1978-07-25 | S. G. Frantz Company, Inc. | Method and apparatus for magnetic separation of particles in a fluid carrier |
IL98744A0 (en) * | 1990-07-06 | 1992-07-15 | Gen Hospital Corp | Method of studying biological tissue using monocrystalline particles |
US5370901A (en) * | 1991-02-15 | 1994-12-06 | Bracco International B.V. | Compositions for increasing the image contrast in diagnostic investigations of the digestive tract of patients |
WO1994003501A1 (en) * | 1992-08-05 | 1994-02-17 | Meito Sangyo Kabushiki Kaisha | Small-diameter composite composed of water-soluble carboxypolysaccharide and magnetic iron oxide |
EP0689430B1 (de) * | 1993-03-17 | 1997-08-13 | Silica Gel Ges.M.B.H | Superparamagnetische teilchen, verfahren zu ihrer herstellung und verwendung derselben |
US5411730A (en) * | 1993-07-20 | 1995-05-02 | Research Corporation Technologies, Inc. | Magnetic microparticles |
WO1996009840A1 (en) * | 1994-09-27 | 1996-04-04 | Nycomed Imaging A/S | Contrast agent |
DE19624426A1 (de) * | 1996-06-19 | 1998-01-02 | Christian Bergemann | Magnetische Flüssigkeiten für den Transport von diagnostisch oder therapeutisch wirksamen Substanzen |
EP0915738B1 (de) * | 1996-08-05 | 2002-01-16 | Schering Aktiengesellschaft | Vorrichtung und verfahren zur abtrennung magnetischer materialien aus pharmazeutischen zubereitungen, deren ausgangs- oder zwischenprodukten sowie mit hilfe dieser vorrichtung hergestellte mittel |
EP1062515B1 (en) * | 1998-02-12 | 2009-11-25 | Immunivest Corporation | Methods and reagents for the rapid and efficient isolation of circulating cancer cells |
GB9921579D0 (es) * | 1999-09-13 | 1999-11-17 | Nycomed Imaging As | |
WO2001037721A2 (en) * | 1999-11-22 | 2001-05-31 | The Research Foundation Of State University Of New York | Magnetic nanoparticles for selective therapy |
US7169618B2 (en) * | 2000-06-28 | 2007-01-30 | Skold Technology | Magnetic particles and methods of producing coated magnetic particles |
DE10151778A1 (de) * | 2001-10-19 | 2003-05-08 | Philips Corp Intellectual Pty | Verfahren zur Ermittlung der räumlichen Verteilung magnetischer Partikel |
JP4890242B2 (ja) * | 2003-04-15 | 2012-03-07 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | 検査エリアにおける状態変数の空間分解を決定する装置及び方法 |
US7619408B2 (en) * | 2003-04-15 | 2009-11-17 | Koninklijke Philips Electronics N.V. | Spatially resolved determination of magnetic particle anisotropy in an area of examination |
JP4647590B2 (ja) * | 2003-04-15 | 2011-03-09 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | 物理的、化学的及び/又は生物学的な特性又は状態変数の空間的に解像される決定の方法 |
US20070258888A1 (en) * | 2003-11-17 | 2007-11-08 | Claus Feldmann | Contrast Agent for Medical Imaging Techniques and Usage Thereof |
EP1738774A1 (de) * | 2005-06-29 | 2007-01-03 | Schering AG | Magnetische Eisenoxidpartikel enthaltende Zusammensetzungen und deren Verwendung in bildgebenden Verfahren |
-
2005
- 2005-06-29 EP EP05014058A patent/EP1738773A1/de not_active Withdrawn
-
2006
- 2006-06-29 GT GT200600288A patent/GT200600288A/es unknown
- 2006-06-29 US US11/476,913 patent/US20070014730A1/en not_active Abandoned
- 2006-06-29 DO DO2006000154A patent/DOP2006000154A/es unknown
- 2006-06-29 JP JP2008518725A patent/JP5366543B2/ja not_active Expired - Fee Related
- 2006-06-29 AR ARP060102810A patent/AR054808A1/es not_active Application Discontinuation
- 2006-06-29 EP EP06762277A patent/EP1898960A1/en not_active Withdrawn
- 2006-06-29 RU RU2008103203/15A patent/RU2420319C2/ru not_active IP Right Cessation
- 2006-06-29 TW TW095123566A patent/TW200800275A/zh unknown
- 2006-06-29 US US11/476,934 patent/US20070036729A1/en not_active Abandoned
- 2006-06-29 BR BRPI0611756-2A patent/BRPI0611756A2/pt not_active Application Discontinuation
- 2006-06-29 WO PCT/EP2006/006320 patent/WO2007000351A1/en active Application Filing
- 2006-06-29 PA PA20068684201A patent/PA8684201A1/es unknown
- 2006-06-29 CN CN2006800234633A patent/CN101365495B/zh not_active Expired - Fee Related
- 2006-06-29 UY UY29643A patent/UY29643A1/es not_active Application Discontinuation
- 2006-07-03 PE PE2006000767A patent/PE20070345A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP5366543B2 (ja) | 2013-12-11 |
EP1738773A1 (de) | 2007-01-03 |
WO2007000351A1 (en) | 2007-01-04 |
RU2420319C2 (ru) | 2011-06-10 |
JP2008544968A (ja) | 2008-12-11 |
EP1898960A1 (en) | 2008-03-19 |
BRPI0611756A2 (pt) | 2012-04-17 |
CN101365495B (zh) | 2013-09-04 |
US20070014730A1 (en) | 2007-01-18 |
CN101365495A (zh) | 2009-02-11 |
RU2008103203A (ru) | 2009-08-10 |
AR054808A1 (es) | 2007-07-18 |
UY29643A1 (es) | 2007-01-31 |
TW200800275A (en) | 2008-01-01 |
PE20070345A1 (es) | 2007-04-20 |
DOP2006000154A (es) | 2008-05-15 |
US20070036729A1 (en) | 2007-02-15 |
PA8684201A1 (es) | 2007-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GT200600288A (es) | Composiciones que contienen particulas magneticas de oxido de hierro, y uso de dichas composiciones en metodos de diagnostico por imagenes | |
PA8684301A1 (es) | Composiciones que contienen particulas magneticas de oxido de hierro, y uso de dichas composiciones en metodos de diagnostico por imágenes | |
ES2525932T3 (es) | Derivados de dihidrotetrabenazina radiomarcados y su uso como agentes de imagenología | |
RU2441668C2 (ru) | Новые визуализирующие агенты | |
ES2562651T3 (es) | Lixisenatida para el uso en el tratamiento de la estenosis o/y la obstrucción del sistema de conductos pancreáticos | |
SG149895A1 (en) | Contrast agents for myocardial perfusion imaging | |
WO2007002109A3 (en) | Multidentate pyrone-derived chelators for medicinal imaging and chelation | |
NO20065048L (no) | Kontrastmidler for myocardial perfusjonsbilleddannelse. | |
DE602006008135D1 (de) | Metallchelate von makrocyclischen polyaminocarbonsäurederivaten und deren anwendung bei der diagnostischen bilderzeugung | |
IL202487A (en) | Annals of 5,5 '- (hydroxyalkyl-diethyl) bis (formylazandyl) bis (2,4,6-triiodophenyl preserved), a diagnostic factor containing them and methods of diagnosis and imaging containing these factors | |
CL2008001297A1 (es) | N-[(1s)-1-(5-fluoropirim idin-2-i1 )etil]-3-(5-isopropoxi-1 h-pirazol-3-il )-3h-imidazo[4,5-b]piridin-5amina o una sal farmacéuticamente aceptabie del mismo; composición farmacéutica que lo comprende; y su uso en el tratamiento del cáncer. | |
Rana et al. | Isolated pancreatic tuberculosis mimicking focal pancreatitis and causing segmental portal hypertension | |
JP6602034B2 (ja) | 標的化分子およびその使用 | |
WO2009070507A3 (en) | Anaplasma phagocytophilum (aph) antigens and antibodies specific for anaplasma | |
Cormode et al. | Nanoparticle contrast agents for CT: their potential and the challenges that lie ahead | |
JP2011519367A5 (es) | ||
Iimuro et al. | Primary squamous cell carcinoma of the liver: an uncommon finding in contrast-enhanced ultrasonography imaging | |
ES2541787A1 (es) | Compuestos y composiciones que comprenden nanotubos de carbono y compuestos de formula (I) y su uso como agentes de contraste | |
TW200744645A (en) | Contrast agents for myocardium perfusion imaging | |
Mohammed et al. | PTU-125 Positive calprotectin but negative investigations-what next? | |
Zhang et al. | Glomus Tumor of the Stomach—A Tumor That Needs to Be Differentiated From Gastrointestinal Stromal Tumor | |
Kim et al. | A case of steroid dependent eosinophilic gastroenteritis presenting as a huge gastric ulcer | |
Kwak et al. | Focal eosinophilic infiltration of the liver mimicking hepatocellular carcinoma | |
Gold et al. | A Unique Cause of an Acute Gastrointestinal Bleed: A Case Report of a Small Bowel Fibroblastic Reticular Cell Sarcoma: 2059 | |
Kucher et al. | Peculiarities of morphological characteristics of the gastric mucosa and duodenal ulcer in patients with chronic obstructive pulmonary disease |